Lv7
5000 积分 2020-12-30 加入
Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers
1个月前
已完结
Current Landscape and Emerging Therapeutic Targets in Diabetic Kidney Disease
2个月前
已完结
Baxdrostat for the treatment of primary aldosteronism: current evidence
2个月前
已完结
Revisiting Hypertension Treatment in Patients With Chronic Kidney Disease
2个月前
已完结
Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design
2个月前
已完结
Recent progress in the diagnosis and treatment of primary aldosteronism
2个月前
已完结
Aldosterone–mineralocorticoid receptor interactions: new insights and therapeutic perspectives in primary aldosteronism
2个月前
已完结
Emerging Therapies for Treatment-Resistant Hypertension: A Review of Lorundrostat and Related Selective Aldosterone Synthase Inhibitors
2个月前
已完结
Emerging trends in small molecule inhibitors targeting aldosterone synthase: A new paradigm in cardiovascular disease treatment
2个月前
已完结
Evolution of mineralocorticoid receptor antagonists, aldosterone synthase inhibitors, and alternative treatments for managing primary aldosteronism
2个月前
已完结
皖公网安备34019202002308
